{"schema_version":"secwatch.filing_event.v1","accession":"0001690585-26-000026","form_type":"8-K","ticker":"DNTH","cik":"0001690585","company_name":"Dianthus Therapeutics, Inc. /DE/","filed_at":"2026-05-22T20:10:16+00:00","discovered_at":"2026-05-22T20:11:00.288650+00:00","generated_at":"2026-05-22T20:12:56.302854+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"confidence":"high","headline":"Dianthus stockholders elect directors, approve say-on-pay, ratify Deloitte at 2026 annual meeting","bullets":["Sujay Kango, Anne McGeorge, and Jonathan Violin elected Class II directors with 42.7M, 34.8M, and 42.8M votes for, respectively.","Advisory vote on executive compensation passed: 41.0M for, 1.7M against, 0.5M abstain, 3.6M broker non-votes.","Ratification of Deloitte & Touche as auditor for 2026 approved: 46.3M for, 5.3K against, 0.5M abstain, no broker non-votes.","All three proposals passed with substantial majorities; no material changes to governance disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001690585-26-000026","json":"https://secwatch.observer/filing/0001690585-26-000026.json","markdown":"https://secwatch.observer/filing/0001690585-26-000026.md","text":"https://secwatch.observer/filing/0001690585-26-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1690585/000169058526000026/0001690585-26-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1690585/000169058526000026/dnth-20260521.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T20:12:56.302854+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}